Ligutan, Jasmin P.

HRN: 23-56-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/23/2023
IV
1.5gms
Prior To OR
Repeat CS With BTL
Waiting Final Action 
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/23/2023
IV
1.5gms
Prior To OR
Repeat CS With BTL
Waiting Final Action 
09/23/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/25/2023
IV
1.5g
Q8
S/p LTCS With BTL
Waiting Final Action 
09/24/2023
CEFUROXIME 500MG (TAB)
09/24/2023
09/30/2023
PO
500mg
BID
SP CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: